Intercellular adhesion molecule-1 (ICAM-1; CD54) is a transmembrane glycoprotein of the immunoglobulin supergene family that is expressed on multiple cell types, including human airway epithelium.
The dried roots of Anthriscus sylvestris (Umbeliferae) have been used in Korean traditional medicine as an antipyretic, an analgesic, and a cough remedy. Deoxypodophyllotoxin (DPT), a major lignan isolated from A. sylvestris, has anti-proliferative, 11) anti-tumor, 12, 13) and antiviral activity. 14) Recently, we reported that DPT reduces the number of infiltrated eosinophils in bronchoalveolar lavage (BAL) fluid and mRNA levels of T helper (Th) 2 cytokines in the lungs of asthmatic mice, 15) leading to anti-asthmatic effects. Moreover, we previously described DPT's strong inhibition of lipopolysaccharide (LPS)-induced nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) via IKK/ NF-kB pathway inhibition in murine macrophage-like RAW264.7 cells. 16) However, the underlying mechanisms for the effect of DPT on ICAM-1 expression have not been reported.
In this study, we examined the inhibitory effect of DPT on TNF-a induced ICAM-1 expression of the murine lung epithelial cell line, LA4. DPT reduced TNF-a induced-ICAM-1 expression by inhibiting the transcription factor, NF-kB.
MATERIALS AND METHODS
Plant Material DPT was isolated from the dried roots of A. sylvestris (Umbeliferae). The chemical structure of the isolated compound was established as deoxypodophyllotoxin in previous studies. Briefly, DPT was isolated from the methylene chloride soluble part of methanol extract of A. sylvestris roots by the silicagel column chromatography and recrystalization. Its chemical structure was established by comparison of 1 H-and 13 C-NMR and optical rotation data with those reported previously.
16) The purity of this compound is above 99.5% based on HPLC analysis.
Reagents Rabbit monoclonal antibody against mouse IkB and b-actin polyclonal antibody were purchased from Cell Signaling Technology, Inc. (Danvers, MA, U.S.A.). Horseradish peroxidase (HRP)-labeled goat anti-rabbit IgG secondary antibody was purchased from Cayman Chemical (Ann Arbor, MI, U.S.A.). HRP-conjugated anti-goat immunoglobulin (IgG) was purchased from Zymed (San Francisco, CA, U.S.A.). Goat polyclonal antibodies specific for mouse ICAM-1 and rabbit polyclonal antibodies against mouse NF-kB and lamin B were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). ECL Western blotting detection reagents were purchased from Amersham Bio- Measurement of Cell Viability Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma) assay. Briefly, LA4 cells were seeded onto 96-well culture plates at 2ϫ10 4 cells/200 ml/well. After incubation with various concentrations of DPT for 20 h, 20 ml of MTT (5 mg/ml) was added to each well. After 4 h incubation, 150 ml of culture medium was removed, and cells were dissolved in 0.4 N HCl/isopropyl alcohol. The optical densities (OD) at 570 nm and 630 nm were measured using a microplate reader (Sunrise, Tecan, Switzerland).
Western Blot Analysis After activation with TNF-a, LA4 cells were washed once with 10 mM phosphate buffered saline (PBS, pH 7.4) containing 150 mM NaCl then lysed in PBS containing 0.1% SDS and 10 mM b-mercaptoethanol. The lysates containing 30 mg of protein were applied to 10% SDS-polyacrylamide gels. Proteins were then transferred to nitrocellulose membranes in 20% methanol/25 mM Tris/192 mM glycine. Membranes were blocked with 5% non-fat dry milk in TTBS (25 mM Tris-HCl, 150 mM NaCl, and 0.2% Tween-20) and probed with either the ICAM-1, IkB, b-actin, lamin B (nuclear extract) or p65 (nuclear extract) antibodies. After 1 h incubation followed by three washes, the membranes were incubated for 1 h with a secondary HRP-conjugated antibody. The protein bands were visualized using an ECL system (Amersham Biosciences Inc.).
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Total RNA from 5ϫ10 5 LA4 cells was extracted with TRIzol reagent (Invitrogen; Carlsbad, CA, U.S.A.) according to the manufacturer's instruction. RT-PCR was performed with a RNA PCR kit (AMV) Ver. 2 (Takara, Shiga, Japan) on a thermal cycler (GeneAmp PCR system 2400, Perkin-Elmer, Norwalk, CT, U.S.A.). One microgram of total RNA from each sample was used as template for reverse transcription reactions using 2.5 pmol oligo (dT) 20 primers and 5 units of Avian Myeloblastosis Virus reverse transcriptase in 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mM MgCl 2 , 1 U/ml RNase inhibitor and 1 mM deoxynucleotide triphosphate (dNTP) mixture. Three microliters of RT product was used for PCR. PCR was carried out in a final volume of 20 ml containing 1 mM MgCl 2 , 1ϫPCR buffer, 1 mM dNTP mixture, 1 U Takara Taq DNA polymerase, and 0.2 mM each primer. Amplification parameters were: 5 min at 94°C, 30 s for denaturation at 94°C, 30 s for primer annealing, 30 s for extension at 72°C, and 5 min at 72°C after the last cycle. Primer sequences and PCR product sizes were as follows: mouse ICAM-1-specific primers (sense: 5Ј-TCG GAG GAT CAC AAA CGA AG-3Ј and antisense: 5Ј-AAC ATA AGA GGC TGC CAT CAC G-3Ј, 432 bp, 30 cycles). Mouse actinspecific primers (sense: 5Ј-CAC CCG CCA CCA GTT CGC CA-3Ј and antisense: 5Ј-CAG GTC CCG GCC AGC CAG GT-3Ј, 574 bp, 23 cycles) were used as the positive controls. After amplification, the PCR products were analyzed by electrophoresis on a 1.2% agarose gel.
Electrophoretic Mobility Shift Assay (EMSA) Cells pretreated with DPT and PDTC for 1 h were treated with TNF-a for 30 min, then nuclear extracts were prepared as described in the manufacturer's protocol (Nuclear Extraction Kit, Panomics, Fremont, CA, U.S.A.). Oligonucleotides corresponding to the downstream NF-kB binding sequences in mouse ICAM-1 promoter were from company and EMSA was performed as described in manufacturer's protocol (EMSA kit, Panomics, Catalog No. 7193 and 7194).
Luciferase Assay A 1520 bp fragment of the promoter region of the mouse ICAM-1 gene (ϩ44 to Ϫ1476) was amplified by PCR using primers 5Ј-GAGGACCAAAGAC-TCTCAG-3Ј and 5Ј-GGAGCTCAGCACTAGCACT-3Ј. The amplified PCR product was cloned into TOPO PCR cloning kit (Invitrogen, Carlsbad, CA, U.S.A.) and digested with KpnI and XhoI. The digested fragment was cloned into the sites of a pGL2 basic vector (Promega, Madison, WI, U.S.A.) and the construct is referred to as pIC1476. LA4 cells were plated into 24-well plates (1ϫ10 5 cells/well) allowed to grow to 50-70% confluence. The mouse ICAM-1 firefly luciferase plasmid (pIC1476) or NF-kB luciferase plasmid was transfected using Lipofectamine Plus TM Reagent (Invitrogen; Carlsbad, CA, U.S.A.) according to the manufacturer's recommendations.
17) Cells were pretreated with DPT for 1 h and then stimulated with TNF-a (50 ng/ml) for 6 h. Then cells were collected and disrupted by sonication in lysis buffer (25 mM Tris-phosphate, pH 7.8, 2 mM EDTA, 1% Triton X-100, and 10% glycerol). The cell lysates were assayed for luciferase activity using a luminometer (Fluostar optima, BMG Labtechnologies, Offenburg, Germany) according to the manufacturer's instructions.
Statistical Analysis All values were represented as an arithmetic meanϮS.D. Two-way analysis of ANOVA followed by Tukey's HSD multiple comparison tests between the TNF-a treated control and DPT treatment groups (SPSS version 17.0).
RESULTS

Structure of DPT and Cytotoxicity to LA4 Cells
The effect of DPT concentration on cell viability (Fig. 1 ) was assessed by MTT assay. We chose 5, 7.5, 10 and 20 nM of DPT for subsequent experiments since there was no significant change in cell viability with these concentrations (Fig. 1) .
DPT Inhibits TNF-a a Induced ICAM-1 mRNA and Protein Expression We examined where ICAM-1 expression is localized within mouse lung epithelial cells. LA4 cells were treated with TNF-a or IL-4 and ICAM-1 mRNA levels were evaluated at several different time points. RT-PCR analysis showed that ICAM-1 transcript was maximal at 2 h, sustained at 5 h, and declined after 10 h (Fig. 2A) . However, IL-4 did not induce ICAM-1 expression in this cell line (data not shown). To determine the effects of DPT on TNF-a induced ICAM-1 mRNA expression, cells were pretreated for 1 h with 5, 7.5, 10 or 20 nM DPT and further stimulated with TNF-a for 5 h. DPT pretreatment dose-dependently inhibited TNF-a induction of ICAM-1 mRNA (Fig. 2B) . As shown in Fig. 2C , when the cells were treated with TNF-a, ICAM-1 protein expression was occurred at 5 h and peaked at 12 h, which persisted until 24 h. Next, we evaluated the effects of DPT on TNF-a induced ICAM-1 protein expression in LA4 cells. Cells were pretreated for 1 h with 5, 7.5, 10 or 20 nM DPT followed by 24 h TNF-a stimulation. Western blot analysis showed that ICAM-1 expression was increased by TNF-a treatment, and DPT dose-dependently reduced this induction (Fig. 2D) .
DPT Inhibits TNF-a a Induced ICAM-1 Promoter Activity To investigate the molecular mechanism of this inhibition, we analyzed whether DPT would repress the activity of the ICAM promoter using a reporter gene assay. ICAM-1 promoter luciferase reporter plasmid (pICAM1476) was transiently transfected into LA4 cells. The increased promoter activity of ICAM-1 elicited by TNF-a was inhibited by 1 h DPT pre-incubation in a dose-dependent manner (Fig. 3A) , indicating transcriptional repression of the ICAM-1 gene by DPT.
DPT Inhibits TNF-a a Induced Ik kB Degradation and p65 Nuclear Translocation The transcription factor, NFkB, is a pleiotropic regulator of many genes involved in immune and inflammatory responses, including the leukocyte adhesion molecules. 18) In response to external stimuli, NF- kB bound IkB is phosphorylated, leading to degradation by the ubiquitin-dependent proteasomal system. This leaves NFkB dimers free to translocate to the nucleus. Therefore, we examined the effect of DPT on TNF-a induced IkB degradation and whether NF-kB is involved in transcriptional activity of the ICAM-1 promoter construct. IkB was degraded 5 min after TNF-a stimulation and returned to normal levels at 120 min (Fig. 4A) . However, 1 h DPT-pretreatment followed by TNF-a for 10 min suppressed TNF-a induced IkB degradation dose-dependently (Fig. 4B) .
Next, we investigated the translocation of NF-kB subunit p65 from the cytosol to the nucleus using Western blot analysis. TNF-a stimulation caused p65 translocation from the cytosol to the nucleus, and DPT inhibited this translocation (Fig. 4C) . These results suggest that DPT represses NF-kB translocation by inhibiting IkB degradation.
DPT Inhibits TNF-a a Induced NF-k kB-Specific DNABinding Activity and NF-k kB Activity To confirm that DPT inhibits TNF-a induced translocation of NF-kB to the nucleus, EMSA was performed with nuclear extracts of LA4 cells. NF-kB DNA-binding activity was detected in nuclear extracts after exposure to TNF-a, and this was blocked by DPT treatment (Fig. 5A) . Pyrrolidine dithiocarbamate (PDTC) was used as a control. 19) The inhibitory effects of DPT on NF-kB activation were further examined using an NF-kB-Luc vector. The NF-kB-Luc reporter vector contained four copies of the NF-kB binding site for determining NF-kB-driven transactivation. Luciferase activity was increased after TNF-a stimulation, and DPT pretreatment dose-dependently inhibited this increase (Fig. 5B) . These results suggest DPT inhibits TNF-a induced NF-kB activation, leading to inhibition of ICAM-1 expression.
DISCUSSION
The adhesion molecule, ICAM-1, influences allergic diseases, such as asthma, where it plays a critical role in airway inflammation. 20) The regulation of ICAM-1 production is therefore a potential target for the development of new therapeutics for asthma. DPT was isolated from A. sylvestris. Recently, we reported that DPT has a dual cyclooxygenase-2 (COX-2) selective/5-lipoxygenase (5-LOX) inhibitory activity, 21) inhibits NO production, 16) has anti-allergic activity, 22) and has anti-asthmatic effects, 15) in vitro and in vivo. Therefore, DPT was applied to murine lung epithelial cells to more thoroughly investigate the underlying mechanisms for antiasthmatic and anti-inflammatory activity.
ICAM-1 is particularly important in inflammatory diseases such as asthma, where it recruits inflammatory cells from the 5 . Effects of DPT on the TNF-a Induced NF-kB-Specific DNA Binding Activity and NF-kB Activity in LA4 Cells LA4 cells were pretreated with DPT (5 or 20 nM) and PDTC (100 mM) for 1 h before stimulation with TNF-a (50 ng/ml) for 30 min (A). Then nuclear extracts were prepared and NF-kB DNA-protein binding activity was determined by EMSA. To measure the effect of DPT on NF-kB transcriptional activity, cells were transfected with the pNF-kB-luc (Clontech Laboratories Inc.), then pretreated with 5, 7.5 or 10 nM DPT for 1 h before incubation with 50 ng/ml TNF-a for 6 h (B). Reporter gene analysis was assayed as described under Materials and Methods. Data are expressed as the meanϮS.D. All data was the arithmetic mean of triplicate determinations. * pϽ0.05 significantly different from the control by the two-way ANOVA test.
blood to the airways and acts as a receptor for many viruses that may exacerbate asthma. 23) Airway epithelial cells express and secrete various immune molecules, such as lipid mediators, oxygen radicals, adhesion molecules, and a wide variety of cytokines, including chemokines. 24) When DPT was added to TNF-a stimulated mouse lung epithelial cells, ICAM-1 mRNA and protein expression was strongly reduced (Fig. 2) , indicating that DPT prevented the expression of this adhesion molecule.
The transcription factor, NF-kB, is a central regulator of the immune system and promotes the transcription of over 150 genes. 25) NF-kB exists as a homo-or hetero-dimer comprised of subunits from the Rel family of proteins which, in vertebrates, consists of p65 (RelA), p50/p105, p52/p100, cRel and RelB. 8) Cytoplasmic NF-kB is bound to inhibitory protein IkB. IkB phosphorylation and subsequent degradation results in NF-kB translocation to the nucleus. DPT inhibited IkB degradation (Fig. 4B) and translocation of p65 to the nucleus (Fig. 4C) . Furthermore, DPT reduced TNF-a induced NF-kB specific DNA-protein binding activity and NF-kB promoter activity (Fig. 5) . To further confirm that DPT affects AP-1 activation, we assessed the effect of DPT on the LPS-induced phosphorylation of extracellular signalregulated kinase (ERK), p38 MAP kinase (p38), and c-Jun N-terminal kinase (JNK). But, the phosphorylation of ERK, MAP kinase p38, and JNK in response to LPS was not changed by DPT treatment (data not shown). These results indicate that the NF-kB pathway is involved in TNF-a induced ICAM-1 expression and DPT inhibits NF-kB activity in mouse lung epithelial cells. At present, the molecular mechanism by which DPT inhibits ICAM expression in LA4 cells is still unclear, although DPT inhibits the NF-kB reporter gene and DNA binding activities, and also degradation of NF-kB inhibitor. Therefore, it will be interesting to investigate how DPT interacts with cellular receptors on the cell surface, as reported in epigallocatechin gallate. 26) In conclusion, DPT dose-dependently inhibited TNF-a induced ICAM-1 expression via suppression of NF-kB activity. Because NF-kB is a critical inflammatory transcription factor, its inhibition by DPT represents a potential therapeutic approach for inflammatory diseases. The precise mechanism by which DPT regulates ICAM expression in LA4 cells is the subject of an ongoing investigation.
